190 related articles for article (PubMed ID: 36077107)
1. DOG1 as an Immunohistochemical Marker of Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis.
Fiorentino V; Straccia P; Tralongo P; Musarra T; Pierconti F; Martini M; Fadda G; Rossi ED; Larocca LM
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077107
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
Abd Raboh NM; Hakim SA
Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
[TBL] [Abstract][Full Text] [Related]
3. DOG1: a novel marker of salivary acinar and intercalated duct differentiation.
Chênevert J; Duvvuri U; Chiosea S; Dacic S; Cieply K; Kim J; Shiwarski D; Seethala RR
Mod Pathol; 2012 Jul; 25(7):919-29. PubMed ID: 22460810
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland.
Hsieh MS; Jeng YM; Jhuang YL; Chou YH; Lin CY
Histopathology; 2016 Apr; 68(5):641-7. PubMed ID: 26212680
[TBL] [Abstract][Full Text] [Related]
5. Is DOG1 really useful in the diagnosis of salivary gland acinic cell carcinoma? - A DOG1 (clone K9) analysis in fine needle aspiration cell blocks and the review of the literature.
Canberk S; Onenerk M; Sayman E; Goret CC; Erkan M; Atasoy T; Kilicoglu GZ
Cytojournal; 2015; 12():18. PubMed ID: 26425134
[TBL] [Abstract][Full Text] [Related]
6. Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands.
Mariano FV; Gómez CA; de Souza do Nascimento J; Dos Santos HT; Egal ES; Montalli VA; Vargas PA; de Almeida OP; Altemani A
Head Neck Pathol; 2016 Dec; 10(4):429-436. PubMed ID: 27177644
[TBL] [Abstract][Full Text] [Related]
7. Expression of SOX10 in Salivary Gland Oncocytic Neoplasms: A Review and a Comparative Analysis with Other Immunohistochemical Markers.
Schmitt AC; Cohen C; Siddiqui MT
Acta Cytol; 2015; 59(5):384-90. PubMed ID: 26619208
[TBL] [Abstract][Full Text] [Related]
8. Combined DOG1 and Mammaglobin Immunohistochemistry Is Comparable to ETV6-breakapart Analysis for Differentiating Between Papillary Cystic Variants of Acinic Cell Carcinoma and Mammary Analogue Secretory Carcinoma.
Said-Al-Naief N; Carlos R; Vance GH; Miller C; Edwards PC
Int J Surg Pathol; 2017 Apr; 25(2):127-140. PubMed ID: 27670353
[TBL] [Abstract][Full Text] [Related]
9. Identification of LMO2 as a new marker for acinic cell carcinoma of salivary gland.
Sheng D; Zhang Y; Xue T; Zhou XY; Li XQ
Diagn Pathol; 2022 Jan; 17(1):15. PubMed ID: 35094691
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of DOG-1 Expression in Salivary Gland Tumours and Comparison with Myoepithelial Markers.
Khurram SA; Speight PM
Head Neck Pathol; 2019 Jun; 13(2):140-148. PubMed ID: 29671211
[TBL] [Abstract][Full Text] [Related]
11. P63 expression can be used in differential diagnosis of salivary gland acinic cell and mucoepidermoid carcinomas.
Sams RN; Gnepp DR
Head Neck Pathol; 2013 Mar; 7(1):64-8. PubMed ID: 23054955
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland.
Hamamoto Y; Harada H; Kohara M; Honma K; Nakatsuka SI; Morii E
Med Mol Morphol; 2021 Mar; 54(1):23-30. PubMed ID: 32488412
[TBL] [Abstract][Full Text] [Related]
13. [Expression of NR4A3/NOR-1 in acinic cell carcinoma of the salivary gland].
Cheng K; Wang X; Wei X; Ma J; Xia QY; Shi QL; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1142-1146. PubMed ID: 33152819
[No Abstract] [Full Text] [Related]
14. High grade transformation of salivary gland acinic cell carcinoma with emphasis on histological diagnosis and clinical implications.
Bury D; Dafalla M; Ahmed S; Hellquist H
Pathol Res Pract; 2016 Nov; 212(11):1059-1063. PubMed ID: 27623207
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma.
Skaugen JM; Seethala RR; Chiosea SI; Landau MS
Cancer Cytopathol; 2021 Feb; 129(2):104-113. PubMed ID: 32809265
[TBL] [Abstract][Full Text] [Related]
16. Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland.
Hsieh MS; Jeng YM; Lee YH
Virchows Arch; 2019 Nov; 475(5):617-624. PubMed ID: 31187185
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of pan-TRK immunohistochemistry in differentiating secretory carcinoma from acinic cell carcinoma of salivary gland-A systematic review.
Sharma P; Sivakumar N; Pandiar D
J Oral Pathol Med; 2023 Mar; 52(3):255-262. PubMed ID: 36207812
[TBL] [Abstract][Full Text] [Related]
18. NR4A3 (NOR-1) Immunostaining Shows Better Performance than DOG1 Immunostaining in Acinic Cell Carcinoma of Salivary Gland: a Preliminary Study.
Owosho A; Tyler D; Adesina O; Odujoko O; Summersgill K
J Oral Maxillofac Res; 2021; 12(1):e4. PubMed ID: 33959239
[TBL] [Abstract][Full Text] [Related]
19. DOG1, p63, and S100 protein: a novel immunohistochemical panel in the differential diagnosis of oncocytic salivary gland neoplasms in fine-needle aspiration cell blocks.
Schmitt AC; McCormick R; Cohen C; Siddiqui MT
J Am Soc Cytopathol; 2014; 3(6):303-308. PubMed ID: 31051720
[TBL] [Abstract][Full Text] [Related]
20. Acinic cell carcinoma of the salivary gland associated with lymphoid-rich stroma. A diagnostic dilemma on cytology: Study of two cases.
Mir F; Rohra P; Aakash N; Furlan K; Cheng L; Ghai R; Reddy V; Gattuso P
Diagn Cytopathol; 2021 Feb; 49(2):E55-E59. PubMed ID: 32761994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
